Related Experiment Videos
Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage
1Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA. juneann-murphy@uokhsc.edu
Abstract:
Human natural killer (NK) cells and T lymphocytes can bind to and inhibit the growth of the yeast-like organism Cryptococcus neoformans. Binding of target cells to NK or T cells also has the potential to modulate cytokine production by the effector cells. In this study, we assessed the ability of C. neoformans to modulate NK cell production, or in some cases T-cell production, of granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumor necrosis factor alpha (TNF-alpha). We found that freshly isolated human NK cells from most individuals make GM-CSF and TNF-alpha constitutively when cultured in vitro. The addition of C. neoformans to T-cell fractions which do not make GM-CSF constitutively did not affect GM-CSF production, but the addition of C. neoformans to NK cell fractions significantly reduced the amounts of GM-CSF produced in most NK cell samples. The reduction in the amount of GM-CSF in C. neoformans-NK cell cocultures could not be attributed to loss of lymphocyte viability or to C. neoformans adsorbing or degrading the cytokine and was dependent on direct contact between the NK cells and cryptococcal cells. GM-CSF was not the only cytokine to be down-regulated. TNF-alpha production was also diminished when NK cells were incubated with C. neoformans. The regulation of both cytokines was at the transcriptional level because GM-CSF and TNF-alpha mRNA levels were lower in NK cell samples incubated with C. neoformans than in NK cell samples incubated without C. neoformans. Diminished production of constitutively produced cytokines resulting from the interaction of NK cells with cryptococcal cells has the potential to affect phagocytic cells in the immediate regional environment and to damp the immune response.
Insights
Cryptococcus neoformans inhibits the production of key immune signaling molecules, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF-alpha), by human natural killer (NK) cells. This interaction occurs via direct cell contact and reduces cytokine mRNA levels.
Area of Science:
- Immunology
- Microbiology
- Cellular Biology
Background:
- Human natural killer (NK) cells and T lymphocytes interact with Cryptococcus neoformans, a yeast-like pathogen.
- This interaction can influence the production of cytokines by immune effector cells.
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF-alpha) are key cytokines involved in immune responses.
Purpose of the Study:
- To investigate the effect of Cryptococcus neoformans on the production of GM-CSF and TNF-alpha by human NK cells and T lymphocytes.
- To determine the mechanism by which C. neoformans modulates cytokine production.
Main Methods:
- Co-culture of human NK cells and T cell fractions with Cryptococcus neoformans.
- Quantification of GM-CSF and TNF-alpha production using in vitro assays.
- Assessment of lymphocyte viability and cytokine levels.
- Measurement of GM-CSF and TNF-alpha mRNA levels to determine transcriptional regulation.
Main Results:
- Freshly isolated human NK cells constitutively produce GM-CSF and TNF-alpha.
- Cryptococcus neoformans significantly reduced GM-CSF production by NK cells, but not by T cells.
- TNF-alpha production by NK cells was also diminished upon incubation with C. neoformans.
- The reduction in cytokines was dependent on direct contact between NK cells and C. neoformans and occurred at the transcriptional level, as indicated by decreased mRNA levels.
Conclusions:
- Cryptococcus neoformans actively down-regulates the production of GM-CSF and TNF-alpha by human NK cells.
- This immune modulation by C. neoformans occurs via direct cell-cell contact and affects cytokine transcription.
- The diminished cytokine production may impact the overall immune response to cryptococcal infections.